TARO-ACYCLOVIR OINTMENT

국가: 캐나다

언어: 영어

출처: Health Canada

유효 성분:

ACYCLOVIR

제공처:

TARO PHARMACEUTICALS INC

ATC 코드:

D06BB03

INN (국제 이름):

ACICLOVIR

복용량:

5%

약제 형태:

OINTMENT

구성:

ACYCLOVIR 5%

관리 경로:

TOPICAL

패키지 단위:

15G/50G

처방전 유형:

Prescription

치료 영역:

ANTIVIRALS

제품 요약:

Active ingredient group (AIG) number: 0115506007; AHFS:

승인 상태:

APPROVED

승인 날짜:

2021-11-09

제품 특성 요약

Page 1 of 33
PRODUCT
MONOG
RAP
H
PR
TARO-ACYCLOVIR
Acy
clovi
r Ointment, USP
5% w/w
ANTIVIRAL AGENT
Date of Preparation:
November 08, 2021
Taro Pharmaceuticals Inc.
130 East Drive,
Brampton, Ontario
Canada L6T 1C1
Control #: 251289
Page 2 of 33
TABLE OF CONTENTS
SUMMARY PRODUCT INFORMATION
................................................................................
3
ACTION AND CLINICAL PHARMACOLOGY
......................................................................
3
INDICATIONS AND CLINICAL USE
.....................................................................................
3
CONTRAINDICATIONS
...........................................................................................................
4
WARNINGS
...............................................................................................................................
5
PRECAUTIONS
.........................................................................................................................
5
DRUG INTERACTIONS
...........................................................................................................
6
ADVERSE REACTIONS
...........................................................................................................
6
SYMPTOMS AND TREATMENT OF OVERDOSAGE
.......................................................... 7
DOSAGE AND ADMINISTRATION
.......................................................................................
7
PHARMACEUTICAL INFORMATION
..................................................................................
8
AVAILABILITY OF DOSAGE FORMS
..................................................................................
9
STORAGE CONDITIONS
.........................................................................................................
9
VIROLOGY
...............................................................................................................................
9
PHARMACOLOGY
.........................................................................